HIGHLIGHTS
- who: Ramesh Nimma et al. from the College of Pharmacy and Pharmaceutical Sciences, Florida AandM University, Tallahassee, FL, USA have published the paper: Combined Transcriptomic and Proteomic Profiling to Unravel Osimertinib, CARP-1 Functional Mimetic (CFM 4.17) Formulation and Telmisartan Combo Treatment in NSCLC Tumor Xenografts, in the Journal: Pharmaceutics 2022, 14, x FOR PEER REVIEW of /2022/
- what: In line with these findings, this study demonstrated considerable TGF-u03b2 expression in H1975 tumors and treatment with the TLM_CFM-F_OSM combination significantly reduced its expression in H1975 tumors, as evidenced by Western blotting, RNA . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.